Caladrius Biosciences Announces Management and Board Changes

By: via Benzinga
Caladrius Biosciences, Inc. (NASDAQ: CLBS) ("Caladrius"), a company combining a leading cell therapy service provider with a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.